Clinical Trial Update: Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether delta-9-tetrahydrocannabinol can prevent chronic pain in patients with acute Complex Regional Pain Syndrome (CRPS); th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome

Drugs mentioned

• Delta-9-tetrahydrocannabinol (tetrahydrocannabinol (THC))

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Complex Regional Pain Syndromes, CRPS | Phase 2 | Status: UNKNOWN